Manufacturing

Bluesight has introduced a fully redesigned 340BCheck platform, describing it as a compliance command center created to support covered entities in maintaining compliance standards...

Large-molecule drugs represent the most advanced frontier of modern therapy, yet their physical complexity presents unique hurdles for manufacturers. Overcoming the inherent instability and delivery obstacles of these fragile compounds is essential for bringing the next generation of life-saving biopharmaceuticals to patients worldwide.

Ensuring the integrity of pharmaceutical compounds from production to the point of care is a fundamental challenge for the industry. New approaches in molecular stabilization and chemical engineering are extending the lifespan of critical medications, preventing degradation in diverse environmental conditions and maintaining therapeutic potency.

Ensuring the reliability of water purification systems within pharmaceutical facilities is vital for maintaining operational continuity and data accuracy. Uniform water quality standards across all laboratory functions reduce variability, streamline compliance, and enhance the overall efficiency of drug testing and development processes.

Ultra-pure water serves as a foundational element within the pharmaceutical quality framework, directly impacting the reliability of analytical results and the safety of manufactured drugs. Integrating high-purity water standards into the broader quality management system ensures compliance with global pharmacopeial requirements and minimizes the risk of environmental contamination.

Eli Lilly and Company is indeed a giant in the pharmaceutical industry, and its GLP-1 diabetes and obesity drug franchise has made it even bigger....

Bringing a novel genetic therapy to market requires a sophisticated understanding of the evolving global regulatory landscape. As health authorities refine their expectations for lipid-based delivery systems, manufacturers must proactively address complex requirements for quality, safety, and manufacturing consistency. By aligning development strategies with established guidelines for chemistry and controls, companies can streamline the approval process and ensure that innovative RNA medicines meet the highest standards of clinical evidence, ultimately accelerating the delivery of life-saving treatments to patients in need.